---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-013684"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:25:58.613343+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BullFrog AI signs feasibility agreement with top-5 pharma for MDD target discovery

## Summary
- Agreement with top-5 global pharma (by 2025 revenue) for bfLEAP platform to identify novel drug targets in major depressive disorder (MDD).
- One-year feasibility deal with milestone payments upon delivery of deliverables; client gets exclusive three-year option on a selected final target.
- MDD market valued >$8B in 2025, expected ~$11B by 2032, per Stellar Market Research.
- CEO Vin Singh calls it 'strong, high-quality validation' and expects the relationship to expand across other R&D areas.
- Agreement filed as exhibit; termination clauses allow 30-day notice for no-cause termination from client.

## SEC filing metadata
- accession: 0001493152-26-013684
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/0001493152-26-013684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-013684
- JSON: https://secwatch.observer/filing/0001493152-26-013684.json
- Plain text: https://secwatch.observer/filing/0001493152-26-013684.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.